Discounted Cash Flow Rating

Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Taro Pharmaceutical Industries Ltd. (TARO)

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/23/1987

Market Cap

1,615,198,185

Shares Outstanding

37,590,000

Weighted SO

37,584,631

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

EGRX --.--%

ANIP --.--%

PAHC --.--%

DCPH --.--%

PBH --.--%

AMPH --.--%

PCRX --.--%

COLL --.--%

ORGO --.--%

Beta

0.5570

Last Div

0.0000

Range

32.67-45.76

Chg

0.0050

Avg Vol

32927

Mkt Cap

1615198185

Exch

NYSE

Country

IL

Phone

972 4 847 5700

DCF Diff

12.2740

DCF

30.6960

Div Yield

0.0000

P/S

2.5671

EV Multiple

23.6115

P/FV

0.9008

Div Yield %

0.0000

P/E

29.9857

PEG

0.2719

Payout

0.0000

Current Ratio

3.6095

Quick Ratio

2.9266

Cash Ratio

1.0050

DSO

102.9495

DIO

230.5744

Op Cycle

333.5239

DPO

50.2809

CCC

283.2431

Gross Margin

0.4847

Op Margin

0.0341

Pretax Margin

0.1314

Net Margin

0.0856

Eff Tax Rate

0.3484

ROA

0.0249

ROE

0.0305

ROCE

0.0119

NI/EBT

0.6516

EBT/EBIT

3.8477

EBIT/Rev

0.0341

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.2058

Rec Turnover

3.5454

Pay Turnover

7.2592

Inv Turnover

1.5830

FA Turnover

2.8916

Asset Turnover

0.2910

OCF/Share

3.4711

FCF/Share

1.9738

Cash/Share

23.3964

OCF/Sales

0.2073

FCF/OCF

0.5687

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

2.3183

Div&CapEx Cov

2.3183

P/BV

0.9008

P/B

0.9008

P/S

2.5671

P/E

29.9857

P/FCF

21.7722

P/OCF

12.3809

P/CF

12.3809

PEG

0.2719

P/S

2.5671

EV Multiple

23.6115

P/FV

0.9008

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Dec 26, 19:00 Procaps Group, S.A. (PROC) Q3 Earnings and Revenues Top Estimates Zacks Investment Research Dec 26, 19:00 Procaps Group, S.A. (PROC) Q3 Earnings and Revenues Top Estimates Zacks Investment Research Dec 26, 19:00 Procaps Group, S.A. (PROC) Q3 Earnings and Revenues Top Estimates Zacks Investment Research Dec 26, 19:00 Procaps Group, S.A. (PROC) Q3 Earnings and Revenues Top Estimates Zacks Investment Research Dec 26, 11:32 Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate

Revenue Product Segmentation